CompaniesByCap
DHR
Danaher Corporation (DHR)
NYSE · Healthcare

Danaher Corporation Revenue 2007–2025

Danaher Corporation annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Danaher Corporation revenue for the quarter ending March 27, 2026 was 6.0 B, a 3.66% increase year-over-year.
  • Danaher Corporation revenue for the twelve months ending March 27, 2026 was 23.7 B, a 3.14% increase year-over-year.
  • Danaher Corporation annual revenue for 2025 was 24.6 B, a 2.90% increase from 2024.
  • Danaher Corporation annual revenue for 2024 was 23.9 B, a 0.06% decrease from 2023.
  • Danaher Corporation annual revenue for 2023 was 23.9 B, a 10.33% decrease from 2022.
  • Danaher Corporation annual revenue for 2022 was 26.6 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Danaher Corporation (DHR) — Frequently Asked Questions

Danaher Corporation (DHR) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $131.50B. In fiscal 2025 it reported revenue of $24.57B and net income of $3.61B. Explore DHR's stock price, financial statements, earnings history, margins and key ratios below.

What is Danaher Corporation's market cap?

Danaher Corporation (DHR) has a market capitalization of $131.50B.

What is the DHR stock price?

DHR trades at $183.63 (-2.54% on the day).

How much revenue does Danaher Corporation make?

Danaher Corporation reported revenue of $24.57B in fiscal 2025.

Is DHR profitable?

In fiscal 2025, Danaher Corporation reported net income of $3.61B.

What is DHR's P/E ratio?

Based on diluted EPS, DHR has a price-to-earnings (P/E) ratio of about 36.4.